Squarepoint Ops LLC Has $559,000 Holdings in Phreesia, Inc. (NYSE:PHR)

Squarepoint Ops LLC lessened its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 85.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,230 shares of the company's stock after selling 127,424 shares during the period. Squarepoint Ops LLC's holdings in Phreesia were worth $559,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Invesco Ltd. increased its holdings in Phreesia by 0.9% during the 4th quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after purchasing an additional 357 shares in the last quarter. NewEdge Advisors LLC increased its holdings in Phreesia by 12.1% during the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after purchasing an additional 459 shares in the last quarter. Johnson Financial Group Inc. increased its holdings in Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after purchasing an additional 896 shares in the last quarter. R Squared Ltd bought a new position in Phreesia during the 4th quarter worth about $30,000. Finally, BankPlus Trust Department bought a new position in Phreesia during the 4th quarter worth about $34,000. Institutional investors own 92.10% of the company's stock.

Phreesia Stock Up 3.9%

Shares of NYSE PHR traded up $1.00 during mid-day trading on Friday, hitting $26.78. The company had a trading volume of 564,167 shares, compared to its average volume of 440,446. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The company has a market capitalization of $1.59 billion, a PE ratio of -18.21 and a beta of 0.74. The firm has a 50-day simple moving average of $24.75 and a two-hundred day simple moving average of $25.47. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.06. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. During the same period last year, the business posted ($0.05) EPS. Phreesia's revenue was up 14.5% on a year-over-year basis. On average, equities analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on PHR shares. Canaccord Genuity Group lowered their target price on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a report on Thursday, May 29th. Citigroup reiterated a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Needham & Company LLC reiterated a "buy" rating and set a $29.00 target price on shares of Phreesia in a report on Thursday, March 13th. Truist Financial increased their price objective on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Finally, Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $31.64.

Insider Activity at Phreesia

In related news, General Counsel Allison C. Hoffman sold 3,496 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $25.32, for a total value of $88,518.72. Following the completion of the sale, the general counsel now directly owns 139,134 shares in the company, valued at approximately $3,522,872.88. This trade represents a 2.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Balaji Gandhi sold 1,827 shares of the firm's stock in a transaction that occurred on Wednesday, March 26th. The stock was sold at an average price of $27.46, for a total transaction of $50,169.42. Following the sale, the chief financial officer now owns 103,591 shares of the company's stock, valued at $2,844,608.86. This trade represents a 1.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 42,474 shares of company stock worth $1,023,208. Insiders own 5.50% of the company's stock.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.